Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

PAR-21-310: Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional)

Closed Closed January 8, 2025 Opportunity PAR-21-310

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2021.

National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on January 8, 2025.

From the official notice on Grants.gov, last changed April 4, 2024. Checked November 7, 2026.

About this NIH notice

Projects funded under PAR-21-310 were run by National Institute on Drug Abuse (NIDA, 4 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read PAR-21-310 in the NIH Guide.

Other notices with this title

National Institutes of Health has posted this title under other numbers: earlier or later rounds, or the same competition for another area. Each has its own dates and may change its rules.

NoticePostedDeadlineStatus
PAR-24-297September 17, 2024Closed July 29, 2026Closed

Key dates

PostedAugust 2, 2021
DeadlineJanuary 8, 2025
Archived by Grants.govFebruary 7, 2025

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

This funding opportunity announcement (FOA) encourages Small Research Grant (R03) applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs, to enable the conduct of small "proof of concept" studies. The R03 is intended to support research projects that can be carried out in a short period of time with limited resources.

Category: Education, Health.

Funded under PAR-21-310 so far

NIH funded 4 projects under PAR-21-310 in fiscal 2023 to 2024, at 4 institutions. The median yearly award was $227,925.

Recently funded projects
ProjectInstitutionFiscal yearAward
Neural mechanisms underlying opioid consumption R03The Pennsylvania State University2024$237,600
Development of novel radioligand for PET imaging targeting the orexin 1 receptor R03University of Pittsburgh at Pittsburgh2024$193,923
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder) R03University of Hawaii at Manoa2023$218,250
Neuroimaging in Pregnancy to Assess Effects of Opioid Use Disorder R03Indiana University Indianapolis2023$237,750

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Drug Use and Addiction Research Programs grants before

From fiscal 2021 to 2025, Drug Use and Addiction Research Programs (93.279) awarded $7.3 billion across 5,071 grant awards, an average of $1.4 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Yale UnivConnecticut150$305 million
The Johns Hopkins UniversityMaryland156$262 million
University of California, San DiegoCalifornia120$242 million
University of Pittsburgh - of the Commonwealth System of Higher EducationPennsylvania100$182 million
New York UniversityNew York62$173 million

Top states: California ($1.1 billion), New York ($773 million), Massachusetts ($613 million), Pennsylvania ($488 million), Maryland ($434 million).

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is PAR-21-310 still open?

No. It closed on January 8, 2025.

Who can apply for Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional)?

Closed January 8, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

Who has been funded under PAR-21-310?

NIH RePORTER lists 4 projects funded under PAR-21-310 in fiscal 2023 to 2024, at 4 institutions. The most were at The Pennsylvania State University, University of Pittsburgh at Pittsburgh, University of Hawaii at Manoa.

Who has won Drug Use and Addiction Research Programs grants before?

The largest recipients over five fiscal years were Yale Univ, The Johns Hopkins University, University of California, San Diego. The program made 5,071 awards worth $7.3 billion in that time.

Similar open grants